Japan Health Authority PMDA
Showing all 14 results
-
Administrative Notice January 25, 2024 Guideline for Ensuring the Quality, Safety, and Efficacy of Biosimilars (PSEHD/PED) Notification No. 0204, Ministry of Health, Labour and Welfare (MHLW), dated February 4, 2020
$10.00 Add to cart -
March 26, 2025 Office of New Drug II Pharmaceuticals and Medical Devices Agency
$50.00 Add to cart -
Sale!
Ministerial Ordinance 136: Standards for Quality Assurance for Drugs, Quasi-drugs, Cosmetics and Medical Devices
Original price was: $75.00.$60.00Current price is: $60.00. Add to cart -
Ministerial Ordinance No. 36: Good Clinical Practice for Medical Devices
$30.00 Add to cart -
Ministerial Ordinance No.2 Regulations for Facilities of Pharmacies in Japan
$100.00 Add to cart -
Ministerial Ordinance No.21 – Good Laboratory Practice for Nonclinical Safety Studies of Drugs
$30.00 Add to cart -
PFSB/ELD Notification No. 0527-1,2010 Vaccines Against the Novel Coronavirus SARS-CoV-2
$30.00 Add to cart -
PFSB/ELD Notification No. 0611-1 June 11, 2012 Guideline for Clinical Evaluation of Diagnostic Radiopharmaceuticals
$50.00 Add to cart -
PFSB/ELD Notification No. 1228-7 Basic Principles of Risk-based Monitoring
$100.00 Add to cart -
PMDA Guideline: Master File System for Drug Substances (MF) in Japan
$30.00 Add to cart -
PMDA Guideline: Application for Accreditation of Foreign Manufacturers (FMA) to PMDA in Japan
$30.00 Add to cart -
PMDA-CPE No.1116002: Procedure for Remote Inspection for Drugs & Regenerative Products
$30.00 Add to cart -
PMDA-PSEHB-MDED No. 0709-2: Ensuring the Quality and Safety of Gene Therapy Products
$150.00 Add to cart -
Provisional Translation (as of December 2024) PFSB/ELD Notification No. 0214-1 February 14, 2013
$10.00 Add to cart
